Literature DB >> 14705971

Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system.

M Ukkonen1, I Elovaara, P Dastidar, T L J Tammela.   

Abstract

OBJECTIVE: Voiding dysfunction is more frequent in primary progressive multiple sclerosis (PPMS) than in other subtypes of MS. We investigated whether lower urinary tract disorders are reflected in the extent of changes in brain and spinal cord detected by magnetic resonance imaging (MRI).
METHODS: Micturition symptoms and specific urodynamic findings in 24 patients with PPMS were related to MRI abnormalities as analysed by segmentation and volumetric analysis.
RESULTS: Urgency and urge incontinence were the most frequent urinary symptoms (83 and 75 %), while detrusor sphincter dyssynergia (DSD) (71%), detrusor hyperreflexia (58%) and obstruction (58%) were the most common micturition dysfunctions. Comparison between patients with detrusor hyperreflexia and those with normal bladder function revealed higher volumes of T2-weighted plaques in the brains of former (P = 0.01). In patients with hypotonic bladder the total brain volume was smaller (P = 0.02) and the number of thoracic plaques in T2-weighted images higher (P = 0.02) compared to patients with normal bladder function. Furthermore, DSD was associated with a higher volume of T2-weighted plaques in the brain (P = 0.02).
CONCLUSIONS: Voiding dysfunction in PPMS is associated with increasing brain and spinal cord abnormalities. Urodynamic investigation is, however, needed for specific definition of micturition disturbances and should be made before therapeutic decisions.

Entities:  

Mesh:

Year:  2004        PMID: 14705971     DOI: 10.1034/j.1600-0404.2003.00184.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  16 in total

1.  The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.

Authors:  Bhupendra O Khatri; John F Foley; Jennifer Fink; John F Kramer; Choon Cha; Xiaojun You; John D Warth; Pam Foulds
Journal:  Int J MS Care       Date:  2014

Review 2.  Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.

Authors:  Paolo Di Benedetto; Cristina Delneri; Emanuele Biasutti; Luisa Monti Bragadin; Tullio Giorgini
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

Review 3.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

4.  Videourodynamics in patients with neurogenic bladder due to multiple sclerosis: our experience.

Authors:  D Caramella; G Donatelli; N Armillotta; F Manassero; C Traversi; P Frumento; D Pistolesi; C Selli
Journal:  Radiol Med       Date:  2011-01-12       Impact factor: 3.469

Review 5.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

Review 6.  A urological challenge: Voiding dysfunction in multiple sclerosis.

Authors:  Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2013-09       Impact factor: 1.862

Review 7.  Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders.

Authors:  Ryuji Sakakibara
Journal:  Clin Auton Res       Date:  2018-08-03       Impact factor: 4.435

8.  Micturitional disturbance due to bilateral medial frontal lobe lesions in a patient with multiple sclerosis.

Authors:  Sachiko Namatame; Hitoshi Mochizuki; Masahiro Ebitani; Nozomu Matsuda; Yoshikazu Ugawa
Journal:  Neurol Sci       Date:  2010-04       Impact factor: 3.307

9.  The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis.

Authors:  Steven J Weissbart; Dasha Pechersky; Anna Malykhina; Thomas Bavaria; Lisa Parrillo; Lily A Arya; Michel Bilello; Alan J Wein; Ariana L Smith
Journal:  Neurourol Urodyn       Date:  2016-01-06       Impact factor: 2.696

10.  Algorithms for the management of overactive bladder.

Authors:  Richard T Kershen
Journal:  Curr Urol Rep       Date:  2009-09       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.